7,7-Dimethyl-2-(pyridin-4-yl)-3H,5H,6H,7H-imidazo[4,5-F]indol-6-one

CAS : 100510-33-6

Ref. 3D-AEA51033

Informations sur le produit

• Nom: 7,7-Dimethyl-2-(pyridin-4-yl)-3H,5H,6H,7H-imidazo[4,5-F]indol-6-one

Description

7,7-Dimethyl-2-(pyridin-4-yl)-3H,5H,6H,7H-imidazo[4,5-F]indol-6-one (DMPI) is a selective inhibitor of ACAT. It has been shown to be an effective drug for the treatment of cancer and bowel disease. DMPI inhibits fatty acid synthesis in cardiac muscle cells by binding to the enzyme ACAT. This leads to reduced fatty acids and increased energy production for cardiac cells. DMPI also has inhibitory properties on isolated heart cells and nitroprusside (NTP).

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 278.31 g/mol
• Formule: C₁₆H₁₄N₄O
• Degré de pureté: Min. 95%